Riskpilot← Back to searchSign inGet full accessEIR AS
ASActiveOrg 989536702Sørkedalsveien 10D, 0369 OsloMedical specialists activities · NACE 8622Est. 20061 employees
Revenue 2024
NOK 96K
-98% vs 2023
EBITDA margin
-291.2%
-110% vs 2023
Equity ratio
364.7%
Financial strength
Net profit 2024
NOK -287K
-220% vs 2023
| Revenue | NOK 96K | -98% |
| EBITDA | NOK -280K | -110% |
| Net profit | NOK -287K | -220% |
| Total assets | NOK 172K | -95% |
| Equity | NOK 626K | -31% |
| Employees | 1 | — |
Legal name
EIR AS
Org number
989536702
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
18. mars 2006
Share capital
NOK 100 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Smertemedisinsk legevirksomhet samt deltagelse i andre selskaper.
Address
Sørkedalsveien 10D, 0369 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 6 859 | 6 956 | 7 344 | 4 759 | 96 |
| Staff expenses | −1 115 | −1 049 | −1 048 | −970 | 7 |
| EBITDA | 3 332 | 3 703 | 3 982 | 2 675 | −280 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 3 332 | 3 703 | 3 982 | 2 675 | −280 |
| Net financials | 0 | −617 | 833 | −1 834 | −7 |
| Profit before tax | 3 332 | 3 087 | 4 815 | 841 | −287 |
| Tax | 735 | 813 | 878 | 602 | −0 |
| Net profit | 2 597 | 2 274 | 3 937 | 239 | −287 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5 464 | 6 853 | 6 498 | 3 376 | 172 |
| Equity | 1 303 | 777 | 674 | 913 | 626 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 4 161 | 6 076 | 5 824 | 2 464 | −454 |
| Total debt | 4 161 | 6 076 | 5 824 | 2 464 | −454 |
EBITDA margin
-291.2%
This company
15.8%
Market median
-1943% vs market
20202024
Equity ratio
364.7%
This company
38.2%
Market median
+855% vs market
20202024
Return on equity
-45.9%
This company
18.4%
Market median
-349% vs market
20202024
Net profit margin
-298.3%
This company
8.1%
Market median
-3783% vs market
20202024
Asset turnover
0.56×
This company
1.12×
Market median
-50% vs market
20202024
Debt / equity
-0.73×
This company
0.62×
Market median
+218% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MA Deputy Member | Deputy Member | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2022 | |
| Former (1) | ||
| Board of Directors | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Veslemøy Holding As
EIR AS Board members of EIR AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mads Alexander Sabel | Deputy Member | 0 companies |
| Wenche Sabel | Chairman | 0 companies |
| Tore Bergfjord | Board of Directors | 0 companies |